[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Pandemic, mostly good news", "description": "Prof Sir Mark Walport, (SAGE)\n\nUK on the edge of losing control\n\nDeath rates\n\nhttps://www.cebm.net/oxford-covid-19-evidence-service/\n\nhttps://www.cebm.net/covid-19/estimating-the-infection-fatality-ratio-in-england/\n\nONS, IFR, as of 4 August, 0.49% \n\nMRC, IFR, as of 28 July, 0.30% \n\nPeak IFR\n\nCases, 240,000\n\nDeaths, 1,351\n\nIFR = 0.56%\n\nOCEBM, 18th August analysis of past 4 weeks UK\n\nhttps://www.cebm.net/covid-19/the-declining-case-fatality-ratio-in-england/\n\nThe trend in deaths, however, continues downwards, indicating that the recent increase in cases is not leading to increased mortality\n\nOur estimate of the CFR as of the 4th of August as 1.5% \u2013  and seemingly still falling\n\nGerman death rates, age adjusted\n\nhttps://www.cebm.net/covid-19/declining-covid-19-case-fatality-rates-across-all-ages-analysis-of-german-data/\n\nGerman estimates of the CFR for people aged 80 +\n\nWeek 18, average CFR was 29%\n\nWeeks 19 \u2013 27, fell to 17% \n\nMid July onwards, CFR was 11% \n\nA decrease of 61%. \n\nGerman CFR in 60-79 years\n\nMarch/April 9%\n\nJuly August 2%\n\nhttps://www.cebm.net/covid-19/declining-covid-19-case-fatality-rates-across-all-ages-analysis-of-german-data/\n\nOxford trials resume\n\nhttps://www.bbc.co.uk/news/uk-54132066\n\nTuesday to Saturday\n\nThe University of Oxford\u2019s Jenner Institute and Oxford Vaccine Group\n\nhttps://www.research.ox.ac.uk/Area/coronavirus-research/vaccine\n\nExpected, some participants will become unwell\n\n18, 000 doses given so far\n\n30,000 participants in the US, UK, Brazil, South Africa\n\nMedicines and Healthcare Products Regulatory Agency\n\nhttps://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency\n\nStudies could now resume\n\nUS\n\nCases, + 245, 584 = 6, 427, 058\n\nDeaths, 192, 388\n\nCases, v deaths\n\nhttps://covid.cdc.gov/covid-data-tracker/#trends_dailytrends\n\nDr. Fauci\n\nhttps://www.instagram.com/p/CE7tWzinTI8/\n\nImmune boosting\n\nYou should consider 2 vitamins\n\nTakes vitamin C and D, lessen your susceptibility to infection\n\nIf you are deficient in vitamin D that does have an impact on your susceptibility to infection, so I would not mind recommending, and I do it myself, vitamin D supplement\n\nGram or 2 of vitamin C, antioxidant\n\nHerbs, not recommended, if you want to use them fine\n\nOther concoctions I would not do\n\nFlu shots\n\nEveryone 6 months or older should get a flu shot\n\nImmunity may wear off, gets this flu shot middle / end October\n\nMost flu starts middle to end of November\n\nAustralia, lightest flu season in memory\n\nParties\n\nNY\n\nCollege related\n\nClusters\n\n88,000 cases on campuses so far\n\n150 colleges with more than 100 cases each\n\nIndoor political rallies\n\nSmoke\n\nInflammation\n\nIncreased susceptibility to infections\n\nCOPD\n\nAsthma\n\nHeart disease\n\nCardiovascular disease\n\nStay indoors\n\nNo exercise\n\nFilters \n\nIonisers\n\nDon\u2019t add to smoke\n\nAir quality in Canada\n\nhttps://www.youtube.com/watch?v=CJN2jBEhhcs", "link": "https://www.youtube.com/watch?v=TZ7vPxWC-3Y", "date_published": "2020-09-13 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Vitamin D, Large scale studies", "description": "Low plasma 25(OH) vitamin D level is associated with increased risk of COVID\u201019 infection: an Israeli population\u2010based study (Federation of European Biochemical Societies Journal)\n\nhttps://febs.onlinelibrary.wiley.com/doi/full/10.1111/febs.15495\n\nVitamin D deficiency is a worldwide pandemic\n\nTo evaluate associations of plasma 25(OH)D levels with the likelihood of coronavirus disease infection and hospitalization\n\nN = 7, 807 \n\nFebruary 1st to April 30th, 2020\n\nParticipants had one previous blood test for the plasma 25(OH)D level\n\nSuboptimal\u2019 or \u2018low\u2019 plasma 25(OH)D. Below 30 ng/mL\n\nSufficiency more than 30 ng/ml. (75 nmol/L)\n\nInsufficiency, 20 \u2013 29 ng/ml\n\nDeficiency less than 20 ng/ml (50 nmol/L)\n\n7, 807 individuals\n\nRisk by age and sex were as expected\n\nObesity not significantly associated with increased risk for COVID\u201019 infection or hospitalization \n\nSufficient vitamin D levels\n\n7, 025 tested negative\n\nLow vitamin D levels\n\n782 tested positive\n\nIncreased likelihood of COVID\u201019 infection\nOdds ratio (OR) of 1.45\n\nIncreased likelihood of hospitalisation\nOR of 1.95\n\nWe concluded that low plasma 25(OH)D levels appear to be an independent risk factor for COVID\u201019 infection and hospitalization.\n\nThe link between vitamin D deficiency and Covid-19 in a large population \n\nhttps://www.medrxiv.org/content/10.1101/2020.09.04.20188268v1.full.pdf\n\n52, 405 infected patients\n\n524, 050 controls\n\nGreater incidence of COVID-19 with lower vitamin D levels\n\nHighest infection prevalence with lowest vitamin D levels\n\nA significant protective effect in those who had supplemented over the previous 4 months\n\nJoint Guidance on Vitamin D in the Era of COVID-19 from the ASBMR, AACE, Endocrine Society, ECTS, NOF, and IOF\n\nhttps://www.nof.org/news/joint-guidance-on-vitamin-d-in-the-era-of-covid-19-from-the-asbmr-aace-endocrine-society-ects-nof-and-iof/\n\nSpend at least 15-30 minutes with direct sun exposure each day\n\nMost older and younger adults can safely take 400-1000 IU daily\n\nVitamin-D and COVID-19: do deficient risk a poorer outcome?  (Lancet)\n\nhttps://www.thelancet.com/journals/landia/article/PIIS2213-8587(20)30183-2/fulltext?fbclid=IwAR0qzV-kiZcVRQ-KeBAkru6hpGUUVVhbywbU3YgV_KSNaE7X7DVmblO9ysk\n\nComparing data across nations, mortality from COVID-19 is clearly higher in some countries than in others\n\nRelative vitamin D status of populations\n\nVitamin D supplementation could be especially important for older people\n\nFunctions\n\nCalcium and phosphate balance\n\nAffecting bone growth and turnover\n\nLow vitamin D status\n\nAssociated with increased susceptibility to infectious disease\n\nNotably, upper respiratory tract infections\n\nTreating the lowest levels gives most percentage benefit\n\nVitamin D and COVID-19\n\nVirus emerged and started its spread in the northern hemisphere at the end of 2019\n\nWhen levels of 25-hydroxyvitamin D are lowest\n\nCOVID-19 mortality was significantly associated with vitamin D status in different populations\n\nNordic countries, widespread fortification of foods\n\nItaly and Spain, prevalence of vitamin D deficiency, surprisingly common\n\nBlack and minority ethnic people\n\nUK, more than four times more likely to die from COVID-19\n\nIn COVID\n\nVitamin D supports production of antimicrobial peptides in the respiratory epithelium\n\nMight help to reduce the inflammatory response\n\nVitamin D is known to interact angiotensin- converting enzyme 2\n\nSARS-CoV-2 down regulates expression of ACE2\n\nVitamin D promotes expression of this gene\n\nRose Anne Kenny\n\nTrinity College Dublin\n\nLead investigator of the Irish Longitudinal Study on Ageing\n\nThe circumstantial evidence is very strong\n\nwe don\u2019t have randomised controlled trial evidence, but how long do you want to wait in the context of such a crisis? \n\nWe know vitamin D is important for musculoskeletal function, so people should be taking it anyway\n\nVitamin D supplements should normally be given to care home residents unless there is an extremely good reason not to do so. \n\nAdrian Martineau \n\nQueen Mary University of London\n\nAt best vitamin D deficiency will only be one of many factors involved in determining outcome of COVID-19\n\nbut it\u2019s a problem that could be corrected safely and cheaply\n\nthere is no downside to speak of, and good reason to think there might be a benefit\n\nVitamin D dose\n\nIU  mcg\n400  10mcg\n800  20mcg\n1,000 25mcg\n2,000 50mcg\n4,000 100mcg", "link": "https://www.youtube.com/watch?v=iNji13yoW9g", "date_published": "2020-09-12 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]